Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.

Abstract

Six hundred ninety patients were enrolled in a multicenter, randomized, double-blind trial comparing the efficacy and safety of cefdinir with those of cefaclor in the treatment of community-acquired pneumonia. Patients received either 10 days of treatment with cefdinir (n = 347) at 300 mg twice daily or 10 days of treatment with cefaclor (n = 343) at 500 mg… (More)

Topics

Cite this paper

@article{Drehobl1997ComparisonOC, title={Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.}, author={Margaret A Drehobl and Pedro Giavina Bianchi and Constance H. Keyserling and Kenneth J Tack and Thomas J Griffin}, journal={Antimicrobial agents and chemotherapy}, year={1997}, volume={41 7}, pages={1579-83} }